Currently serving as national counsel for four companies in multidistrict litigation involving dietary supplements containing ephedra currently pending in the Southern District of New York. Appointed to Defendants Steering Committee for MDL and have primary responsibility for Daubert hearing and coordination of defense effort relative to experts and causation issues.
Serving as national counsel for a pharmaceutical manufacturer in multidistrict litigation pending in the District of Arkansas and state coordinated proceedings involving claims arising from use of hormone replacement therapy products. Appointed to Defendants Steering Committee for MDL.
Secured reversal in Ohio Supreme Court of trial court’s certification of class action in OxyContin litigation.
Secured dismissal of several product liability lawsuits involving asbestos containing products in Madison County, Illinois.
Served as national counsel for welding rod distributor in welding rod product liability litigation. To date, have succeeded in having company summarily dismissed from more than 17,000 cases in nearly two dozen states, including the multi-district litigation pending in the Northern District of Ohio.
Secured dismissal of welding rod product liability claim brought by more than 3,200 plaintiffs in state court in West Virginia.
Secured dismissal of $40 million product liability action arising out of an explosion at a data center in Salt Lake City, allegedly caused by onsite computer systems.
Successfully defended product liability action involving heat wraps for one of the world’s largest consumer products manufacturers.
Secured summary judgment in trial court in case involving allegations that ingestion of prescription drug caused father to murder two-year-old son. The trial court’s decision was affirmed by the Eighth Circuit Court of Appeals. This case attracted national attention, including a story on the CBS News program 48 Hours.
National counsel for multiple pharmaceutical companies for their cases involving claims arising from use of anti-depressant drugs. Secured dismissal of claims against clients on a number of occasions during early part of proceedings as a result of thorough fact investigation and technical expertise.